The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 21, 2023 | Sensenig Bethany | Chief Financial Officer | Sell(S) | 9K | $1.21 | $11K |
| Mar 29, 2023 | Ventimiglia Samantha | Director | Grant(A) | 8K | — | — |
| Mar 29, 2023 | Constantino Michael T. | Director | Grant(A) | 8K | — | — |
| Mar 29, 2023 | Johnson Lorin K | Director | Grant(A) | 8K | — | — |
| Mar 29, 2023 | Rice Yehuda Michael | Director | Grant(A) | 8K | — | — |
| Mar 29, 2023 | Sirgo Mark A | Director | Grant(A) | 8K | — | — |
| Mar 27, 2023 | Temperato John | Chief Executive Officer, Director | Grant(A) | 69K | — | — |
| Mar 27, 2023 | Sensenig Bethany | Chief Financial Officer | Grant(A) | 50K | — | — |
| Jul 6, 2022 | Temperato John | Chief Executive Officer, Director | Buy(P) | 125K | $0.23 | $29K |
| Jul 1, 2022 | Sirgo Mark A | Director | Grant(A) | 175K | $0.25 | $44K |
| Jun 22, 2022 | Constantino Michael T. | Director | Grant(A) | 143K | — | $0 |
| Jun 22, 2022 | Johnson Lorin K | Director | Grant(A) | 143K | — | $0 |
| Jun 22, 2022 | Rice Yehuda Michael | Director | Grant(A) | 143K | — | $0 |
| Jun 22, 2022 | Ventimiglia Samantha | Director | Grant(A) | 143K | — | $0 |
| Jun 22, 2022 | Sirgo Mark A | Director | Grant(A) | 143K | — | $0 |
| May 23, 2022 | Constantino Michael T. | Director | Buy(P) | 16K | $0.48 | $8K |
| May 18, 2022 | Sirgo Mark A | Director | Buy(P) | 106K | $0.47 | $50K |
| May 18, 2022 | Temperato John | Chief Executive Officer, Director | Buy(P) | 50K | $0.45 | $23K |
| Mar 3, 2022 | Temperato John | Chief Executive Officer, Director | Buy(P) | 100K | $0.56 | $56K |
| Mar 3, 2022 | Sirgo Mark A | Director | Buy(P) | 86K | $0.58 | $50K |
| Feb 21, 2022 | Temperato John | Chief Executive Officer, Director | Grant(A) | 2.5M | — | $0 |
| Jan 18, 2022 | Sensenig Bethany | Chief Financial Officer | Grant(A) | 1.3M | — | $0 |
| Dec 2, 2021 | Sirgo Mark A | Director | Buy(P) | 50K | $0.89 | $45K |
| Nov 18, 2021 | Temperato John | Chief Executive Officer, Director | Buy(P) | 50K | $1.05 | $53K |
| Nov 18, 2021 | Sirgo Mark A | Director | Buy(P) | 20K | $1.06 | $21K |
| Oct 1, 2021 | Ventimiglia Samantha | Director | Grant(A) | 150K | $1.29 | $194K |
| Sep 14, 2021 | Sitar Edward J | Chief Financial Officer | Buy(P) | 15K | $1.22 | $18K |
| Sep 7, 2021 | Sirgo Mark A | Director | Buy(P) | 74K | $1.36 | $100K |
| Aug 24, 2021 | Constantino Michael T. | Director | Buy(P) | 18K | $1.14 | $21K |
| Aug 20, 2021 | Sirgo Mark A | Director | Buy(P) | 25K | $1.10 | $28K |
| Aug 18, 2021 | Temperato John | Chief Executive Officer, Director | Buy(P) | 25K | $1.05 | $26K |
| Jun 25, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell(S) | 16.0M | $1.21 | $19.3M |
| Jun 24, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell(S) | 319K | $1.38 | $441K |
| Jun 23, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell(S) | 842K | $1.36 | $1.1M |
| Jun 22, 2021 | Sirgo Mark A | Director | Grant(A) | 90K | — | $0 |
| Jun 22, 2021 | Johnson Lorin K | Director | Grant(A) | 90K | — | $0 |
| Jun 22, 2021 | Constantino Michael T. | Director | Grant(A) | 90K | — | $0 |
| May 11, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Option exercise(X) | 19K | $0.62 | $12K |
| May 11, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Option exercise(X) | 13K | $0.70 | $9K |
| May 11, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Option exercise(X) | 19K | — | $0 |
| May 11, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Option exercise(X) | 13K | — | $0 |
| Apr 5, 2021 | Sirgo Mark A | Director | Buy(P) | 300K | $1.00 | $300K |
| Apr 5, 2021 | Temperato John | Chief Executive Officer, Director | Buy(P) | 100K | $1.00 | $100K |
| Apr 5, 2021 | Sitar Edward J | Chief Financial Officer | Buy(P) | 50K | $1.00 | $50K |
| Aug 20, 2020 | Constantino Michael T. | Director | Buy(P) | 27K | $0.75 | $20K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).